All stock lists
DarioHealth Corp. (NASDAQ:DRIO)
US · Delayed Price · Currency is USD
Healthcare · Medical - Specialties
3.61-0.16 (-4.24%)
Market cap
$35.4M
Health Score
Analyst consensus
Listed since
Mar 14, 2016
Website
Insider Score
––Not scored
DRIO Insider Score
Insiders here have filed 8 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
DRIO analyst forecast
DRIO analyst consensus
Hold1 ratings
Buy 0 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
DRIO 12-month price target
No published price targets in the last 12 months.
Best analysts covering DRIO
- Stifel0%success rate · 3 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
DRIO analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | TD Cowen | Hold | — | — | Reiterated | 2026-08-12 |
| — | Stifel | Buy | — | — | Reiterated | 2026-05-14 |
| — | TD Cowen | Hold | — | — | Reiterated | 2026-05-13 |
| — | Stifel | Buy | — | — | Reiterated | 2026-03-20 |
| — | Stifel | Buy | — | — | Reiterated | 2025-03-11 |
| — | Stifel | Buy | — | — | Reiterated | 2024-04-01 |
| — | Alliance Global Partners | Buy | — | — | Reiterated | 2023-08-11 |
| — | Stifel | Buy | — | — | Reiterated | 2023-07-25 |
| — | Craig-Hallum | Buy | — | — | Reiterated | 2023-05-12 |
| — | Alliance Global Partners | Buy | — | — | Reiterated | 2022-11-16 |
| — | Aegis Capital | Buy | — | — | Reiterated | 2022-08-18 |
| — | Cowen & Co. | Outperform | — | — | Reiterated | 2022-08-16 |
| — | Aegis Capital | Buy | — | — | Reiterated | 2022-05-16 |
| — | Cowen & Co. | Outperform | — | — | Reiterated | 2022-05-16 |
| — | Alliance Global Partners | Buy | — | — | Upgraded | 2022-05-13 |
| — | Aegis Capital | Buy | — | — | Reiterated | 2022-01-26 |
| — | Aegis Capital | Buy | — | — | Reiterated | 2021-08-19 |
| — | Cowen & Co. | Outperform | — | — | Reiterated | 2021-04-22 |
| — | Stifel | Buy | — | — | Reiterated | 2021-03-23 |
| — | Aegis Capital | Buy | — | — | Reiterated | 2021-02-08 |
| — | ThinkEquity | Buy | — | — | Reiterated | 2020-11-25 |
| — | Craig-Hallum | Buy | — | — | Reiterated | 2020-11-25 |
| — | Aegis Capital | Buy | — | — | Reiterated | 2020-11-25 |
| — | Aegis Capital | Buy | — | — | Reiterated | 2020-08-17 |
| — | ThinkEquity | Buy | — | — | Reiterated | 2020-06-22 |
| — | Craig-Hallum | Buy | — | — | Reiterated | 2020-05-13 |
| — | Craig-Hallum | Buy | — | — | Reiterated | 2019-06-06 |
| — | Chardan Capital | Buy | — | — | Reiterated | 2018-04-09 |
| — | Aegis Capital | Buy | — | — | Reiterated | 2017-08-29 |
| — | Rodman & Renshaw | Buy | — | — | Reiterated | 2016-05-09 |
DRIO earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-19 | -2.44 | -0.80 | $5.0M | $5.2M |
| 2026-05-13 | -1.09 | -0.81 | $5.5M | $5.6M |
| 2026-08-11 | -1.22 | -0.85 | $5.9M | $5.2M |
| 2026-11-12 | -0.51 | 0.00 | $5.2M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.